ACC Congress coverage: the interventional cardiology perspective

Alessandro Sticchi interviews David E. Kandzari about the results of the Target Bp I Randomized Trial which he presented at ACC.24.

The trial reports mixed results on nerve ablation for high blood pressure with a modest but statistically significant difference in lowered blood pressure at 3 months,...

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Aaysha Cader interviews Rasha Al-Lamee and Michael Foley about the results of the ORBITA-COSMIC trial presented at ACC.24 in Atlanta.

Results showed that coronary sinus reducer relieved angina symptoms but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its mechanism remains...

Luigi Biasco interviews Moritz Seiffert about the one-year outcomes of the randomized DEDICATE-DZHK6 trial which he presented at ACC.24 in Atlanta.

TAVR was found non-inferior to SAVR in low-risk patients, showing decreased rates of death or stroke at one year. The trial supports TAVR's safety and efficacy, highlighting...

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.